These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34043770)

  • 1. Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data.
    El Sharouni MA; Ahmed T; Witkamp AJ; Sigurdsson V; van Gils CH; Nieweg OE; Scolyer RA; Thompson JF; van Diest PJ; Lo SN
    Br J Surg; 2021 May; 108(5):550-553. PubMed ID: 34043770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
    Verver D; van Klaveren D; Franke V; van Akkooi ACJ; Rutkowski P; Keilholz U; Eggermont AMM; Nijsten T; Grünhagen DJ; Verhoef C
    Br J Surg; 2019 Feb; 106(3):217-225. PubMed ID: 30307046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma.
    Ipenburg NA; Nieweg OE; Ahmed T; van Doorn R; Scolyer RA; Long GV; Thompson JF; Lo S
    Br J Surg; 2019 Sep; 106(10):1319-1326. PubMed ID: 31310333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node-positive melanoma without the need for completion lymph node dissection.
    Verver D; Rekkas A; Garbe C; van Klaveren D; van Akkooi ACJ; Rutkowski P; Powell BWEM; Robert C; Testori A; van Leeuwen BL; van der Veldt AAM; Keilholz U; Stadler R; Eggermont AMM; Verhoef C; Leiter U; Grünhagen DJ
    Eur J Cancer; 2020 Jul; 134():9-18. PubMed ID: 32454396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
    El Sharouni MA; Varey AHR; Witkamp AJ; Ahmed T; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; Lo SN; van Gils CH
    Br J Dermatol; 2021 Aug; 185(2):412-418. PubMed ID: 33657653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
    Bertolli E; Franke V; Calsavara VF; de Macedo MP; Pinto CAL; van Houdt WJ; Wouters MWJM; Duprat Neto JP; van Akkooi ACJ
    Ann Surg Oncol; 2019 Feb; 26(2):395-405. PubMed ID: 30456681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes.
    Li AT; Law J; Ch'ng S; Scolyer RA; Thompson JF; Lo SN; Varey AHR
    Eur J Cancer; 2023 Aug; 189():112901. PubMed ID: 37263897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival in patients with thin melanoma: results from a multi-institution study.
    Maurichi A; Miceli R; Camerini T; Mariani L; Patuzzo R; Ruggeri R; Gallino G; Tolomio E; Tragni G; Valeri B; Anichini A; Mortarini R; Moglia D; Pellacani G; Bassoli S; Longo C; Quaglino P; Pimpinelli N; Borgognoni L; Bergamaschi D; Harwood C; Zoras O; Santinami M
    J Clin Oncol; 2014 Aug; 32(23):2479-85. PubMed ID: 25002727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.
    Bertolli E; de Macedo MP; Calsavara VF; Pinto CAL; Duprat Neto JP
    J Am Acad Dermatol; 2019 Mar; 80(3):722-726. PubMed ID: 30395920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor.
    El Sharouni MA; Stodell MD; Ahmed T; Suijkerbuijk KPM; Cust AE; Witkamp AJ; Sigurdsson V; van Diest PJ; Scolyer RA; Thompson JF; van Gils CH; Lo SN
    Ann Oncol; 2021 Mar; 32(3):375-383. PubMed ID: 33253862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy.
    Khosrotehrani K; van der Ploeg AP; Siskind V; Hughes MC; Wright A; Thomas J; Barbour A; Allan C; Bayley G; Eggermont A; Verhoef C; Smithers BM; Green AC
    Eur J Cancer; 2014 May; 50(7):1301-9. PubMed ID: 24613127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of sentinel node biopsy status in cutaneous melanoma: a 21-years prospective study from a single institution.
    Avilés-Izquierdo JA; Nieto-Benito LM; Lázaro-Ochaita P; Escat-Cortés JL; Marquez-Rodas I; Mercader-Cidoncha E
    Clin Transl Oncol; 2020 Sep; 22(9):1611-1618. PubMed ID: 32065344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal and systemic recurrence following observation of a positive sentinel lymph node in melanoma.
    Bartlett EK; Lee AY; Spanheimer PM; Bello DM; Brady MS; Ariyan CE; Coit DG
    Br J Surg; 2020 Oct; 107(11):1480-1488. PubMed ID: 32484242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
    Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
    Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.